Antheia
Latest round
- Debt
Last raised
- Oct 2026
Total raised
- $233M
Investors
- 11
About Antheia
Founded in 2015 and headquartered in Menlo Park, US, Antheia, Inc. specializes in biosynthetic pharmaceutical production. The company's founders include Christina Smolke, Kristy Hawkins, and Lauren Zatulove. In June 2025, Antheia, Inc. Antheia specializes in the production of biosynthetic Key Starting Materials (KSMs) and Active Pharmaceutical Ingredients (APIs) designed to address the complexities and demands of modern medicine. Leveraging synthetic biology, the company offers an innovative platform that enhances the reliability, efficiency, and sustainability of pharmaceutical supply chains. Antheia’s solutions aim to mitigate drug shortages and the inefficiencies associated with traditional agricultural sourcing, which is often vulnerable to climate variability and other agricultural challenges. The company's products serve a diverse client base, including pharmaceutical manufacturers and healthcare providers, focused primarily on the North American and European markets.Antheia generates revenue primarily through B2B transactions with pharmaceutical manufacturers and healthcare partners. The company’s business model is structured around long-term partnerships and collaborations, particularly in biomanufacturing, which aligns with the growing demand for reliable pharmaceutical ingredients. Clients engage in contractual agreements covering the supply of biosynthetic KSMs and APIs, reflecting the strategic importance of these products in the manufacturing of essential medications. Specific pricing structures are customized based on contract terms and volume of products ordered, ensuring financial arrangements meet the unique needs of each client.In July 2024, Antheia, Inc. This strategic approach aims to strengthen Antheia's role in the pharmaceutical industry while ensuring a reliable supply of essential medicines.S. manufacturing, and support new innovation programs in Singapore and Asia.
Who invested in Antheia
11 investors across 4 rounds
See all investors in Antheia
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Antheia
Who invested in Antheia?
Antheia has 11 investors on record across 4 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Antheia raised?
Antheia has raised 4 venture rounds. Sign up free to see how much each round raised and the total.
When did Antheia last raise money?
Antheia's most recent round on record is a Debt, in Oct 2026.
What does Antheia do?
Founded in 2015 and headquartered in Menlo Park, US, Antheia, Inc.
Where is Antheia headquartered?
Antheia is headquartered in Menlo Park, US.
Which VCs invest in companies like Antheia?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Antheia's stage. Their profiles are linked below.
VCs backing biotechnology startups at Debt
Raising like Antheia? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.